Asia Pacific Allergy Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Allergy Type, and Treatment

The Asia Pacific allergy treatment market is expected to reach US$ 9,991.64 million by 2028 from US$ 5,662.06 million in 2020; it is estimated to grow with a CAGR of 7.4% from 2021 to 2028. The growth of the market is attributed to increasing adoption of immunotherapy in allergy treatment, and developments in food allergy treatments. However, the lack of awareness about allergy treatments is a key factor restraining the market growth.

The allergies are hypersensitive responses from human immune system to the substance that come in contact with body. Severe allergy can be life threatening which disturb the normal functioning of organs such as asthma causes poor functioning of lungs. The most effective treatment for allergy is to avoid the known allergens, while there are medications such as steroids and antihistamines and other therapies which prevent allergies. As per statistics published by Parliament of Australia, the National Health Survey suggests 4.6 million Australians (19.3 per cent of the population) were affected by allergic rhinitis in 2019. Immunotherapy has shown positive and long-term benefits in allergic patients and is suitable for self-administration and medicine usage in homecare settings. Therefore, immunotherapy has emerged as a safe and effective alternative subcutaneous route for both chronic and recurrent allergies. Also, developments in the pharmaceuticals industry have enabled companies to offer treatment for varied allergy reactions. Such developments in the food allergy treatment options and their effectiveness are the factors boosting the allergy treatment market growth.

With the spread of the COVID-19 pandemic, it was discovered that a significant number of people around the world were suffering from chronic respiratory diseases, such as respiratory allergies, such as allergic rhinitis, and sinusitis. Certainly, COVID-19 increases the risk of aggravating asthma and allergic diseases, but the government and private agencies are guiding for the treatments. As Asia Pacific passes through these challenging times of the COVID-19 pandemic, the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) via its COVID-19 Task Force is carefully monitoring and updating Food and Drug Administration (FDA), WHO and other crucial scientific information on COVID-19 on its website COVID-19 resource section. Thus, the rising need for allergy treatment is likely to boost the market.

The Asia Pacific Allergy treatment market, based on the allergy type was segmented into eye allergy, rhinitis, asthma, skin allergy, food allergies, and other allergies. In 2020, the rhinitis segment held the largest share of the market, whereas the food allergies segment is expected to grow at the fastest rate during the coming years.

The Asia Pacific Allergy treatment market, based on the treatment was segmented into anti-allergy drugs, and immunotherapy. In 2020, the anti-allergy drugs segment held the largest share of the market. However, the immunotherapy is expected to grow at the fastest rate during the coming years.

A few of the primary and secondary sources associated with this report on the Asia Pacific allergy treatment market are Indian College of Allergy, Asthma, and Applied Immunology (ICAAI), Australian Society of Clinical Immunology and Allergy (ASCIA) and National Institute of Allergy and Infectious Diseases (NIAID).

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific allergy treatment market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific allergy treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.